Atossa Therapeutics (ATOS.US) Latest Stock News - Major News Analysis

Quote List Quote List

Event Tracking

Dec15

Atossa Therapeutics Showcases Positive Results of (Z)-endoxifen at SABCS

13:01

Dec11

Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation

13:02

Nov13

Atossa Therapeutics released FY2025 9 Months Earnings on November 12, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.1845

04:00

Atossa Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0672 (forecast USD -0.065)

04:00

Oct6

Atossa Therapeutics to make adjustments to improve operational sustainability and financial prospects

12:22

Oct4

Jason McCarthy Highlights Atossa Therapeutics' Oral Endoxifen Potential

12:16

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -8.692 M, EPS -0.0672

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -8.423 M, EPS -0.0652

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -6.718 M, EPS -0.052

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change